Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details) - Schedule of warrant activities

v3.22.2.2
Shareholders' Deficit (Details) - Schedule of warrant activities - Warrant [Member]
 9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]  
Number of Warrants, Balance Outstanding, Beginning (in Shares) | shares 17,500,000
Weighted Average Exercise Price, Balance Outstanding, Beginning $ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning 4 years 8 months 1 day
Aggregate Intrinsic Value, Balance Outstanding, Beginning (in Dollars) | $
Number of Warrants, Granted (in Shares) | shares 33,000,000
Weighted Average Exercise Price, Granted $ 0.025
Weighted Average Remaining Contractual Term (Years), Granted
Aggregate Intrinsic Value, Granted (in Dollars) | $
Number of Warrants, Cancelled (in Shares) | shares (16,500,000)
Weighted Average Exercise Price, Cancelled $ 0.05
Weighted Average Remaining Contractual Term (Years), Cancelled
Aggregate Intrinsic Value, Cancelled (in Dollars) | $
Number of Warrants, Balance Outstanding, Ending (in Shares) | shares 34,000,000
Weighted Average Exercise Price, Balance Outstanding, Ending $ 0.011
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 3 years 11 months 26 days
Aggregate Intrinsic Value, Balance Outstanding, Ending (in Dollars) | $
Number of Warrants, Exercisable (in Shares) | shares 34,000,000
Weighted Average Exercise Price, Exercisable $ 0.011
Weighted Average Remaining Contractual Term (Years), Exercisable 3 years 11 months 26 days
Aggregate Intrinsic Value, Exercisable (in Dollars) | $